Epileptic encephalopathy with electrical status epilepticus in sleep (ESES) is an epilepsy syndrome occurring almost exclusively in children, usually at an age between 4 and 12 years. It is characterised by abundant sleep-induced epileptic activity in the electroencephalogram (EEG) and by acquired cognitive and behavioural deficits. The goal of treatment is to prevent further decline or even improve cognitive functioning. Based on mostly small and retrospective studies, corticosteroids and clobazam are regarded by many clinicians as the most effective pharmacological treatments. This European multicentre randomised controlled trial is designed to compare the effects of corticosteroids and clobazam on cognitive functioning after 6 months. Secondary outcomes include cognitive functioning after 18 months, EEG abnormalities in sleep, safety and tolerability, and seizure frequency. We also aimed at investigating whether treatment response in epileptic encephalopathy with ESES can be predicted by measurement of inflammatory mediators and autoantibodies in serum.
Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*) / v.d.M. Bart, A. Alexis, P. Emilio, v.T. Heleen C, L. Frans S S, B. Kees P J, J. Floor E, P. Veggiotti. - In: TRIALS. - ISSN 1745-6215. - 21:1(2020 Dec).
|Titolo:||Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*)|
VEGGIOTTI, PIERANGELO (Ultimo)
|Parole Chiave:||CSWS; Clobazam; Cognition; Corticosteroids; ESES; Epilepsy; Neuropsychology; Sleep|
|Settore Scientifico Disciplinare:||Settore MED/39 - Neuropsichiatria Infantile|
|Data di pubblicazione:||dic-2020|
|Data ahead of print / Data di stampa:||23-nov-2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1186/s13063-020-04874-2|
|Appare nelle tipologie:||01 - Articolo su periodico|